BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Santen Pharmaceutical to Buy Novagali Pharma for $136 Million


9/28/2011 6:50:17 AM

Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French eye care company Novagali from its main shareholders, followed by a tender offer for the rest of the company. Santen, which expects to pay about 100 million euros($136 million)for the entire company, says on its website that it is the leader in Japan for prescription ophthalmics with a market share of nearly 40 percent, but it is also present in anti-rheumatic drugs. Novagali shareholders Edmond de Rothschild Investment Partners, Auriga Partners, IdInvest Partners and CDC Innovation have agreed to sell their shares at 6.15 euros each -- a 71.3 percent premium to Novagali's closing share price on Sept. 27. Novagali said.

Read at Reuters
Read at Bloomberg
Read at News Release
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->